• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: antibody drug conjugate of metal-binding motif-introduced trastuzumab antibody variant and monomethyl auristatin E
Date Designated: 07/30/2018
Orphan Designation: Treatment of Gastric Cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Alteogen, Inc.
62 Yuseong-daero 1628beon-gil
Daejeon, Daejeon
South Korea

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.